@hematogones@KurtSchaberg Great! Love it.
WHO has added a new rhabdomyosarcoma type/category as “Rhabdomyosarcoma with TFCP2 rearrangement” in online - Head & Neck (5th Ed.)
In soft tissue & Bone (5th Ed.), it has been added as well but under subtype of “Spindle cell / Sclerosing Rhabdomyosarcoma”
I betcha you've had debates in your group - SSL vs microvesicular hyperplastic polyps. What if I tell you they may be part of a spectrum? Could that be true? Read all about it 👇🏿 We have expert weigh-in on this review @RaulSGonzalezMD@ALBoothMD https://t.co/I2bRnuYFoZ 🌟Free access
👇🔥#OriginalResearch#OpenAccess🔓
"Novel histological repertoire of crypt-associated anomalies in inflamed colon mucosa"
by Rubio et al.
https://t.co/2gUhITjfrQ
#GIpath
New! Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology
https://t.co/ZeTBpCRFcU
#CytoPath
I finished revising my notes on "Mesenchymal Tumors of the GI tract" to include pictures on my website "Kurt's Notes" (https://t.co/OKmaPvGQpJ)
🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬
Full notes available here: https://t.co/Aw07XAbXC6
Hey #PathTwitter 🙂, Can you help me make a list 📝 of 100 reasons to choose #pathology for my conference/presentation to medical students & graduates? I’ll convince them to join our club! 😊 🏥🔬🩸🦠🧬🧪🧠🫁🫀
I am so lucky to have found #pathology 🙏🏾😍 🔬
Despite all the fear mongerers trying to dissuade me, the wrong generalizations, and the hesitation of not seeing patients directly, I am glad I persevered. I can’t think of anything more intellectually and professionally fulfilling (for me)
#ILookLikeAPathologist
Calling all #medicalstudents to make an informed decision about this incredible field of clinical medicine!
📸 @CEKanakisMD 🙏🏾